Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study

Wong, CKH; Man, KKC; Shi, M; Chan, EW; Ho, CW; Tse, ETY; Wong, ICK; Lam, CLK

Wong, CKH (reprint author), Univ Hong Kong, Dept Family Med & Primary Care, Li Ka Shing Fac Med, Hong Kong, Peoples R China.

PLOS MEDICINE, 2019; 16 (12):

Abstract

Author summaryWhy was this study done? For those who fail dual therapy of metformin and sulfonylurea (Met-SU) after treatment initiation for 3 months,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索